Pretrial Proceedings Over Link Between Recalled Valsartan and Cancer To Continue Through Late 2021
Valsartan proceedings will continue throughout 2021, with the first trials unlikely to be held before 2022.…
«
»
Valsartan proceedings will continue throughout 2021, with the first trials unlikely to be held before 2022.…
Zantac lawsuits continue to be filed as more former users learn the heartburn drug they used for years may have caused them to develop cancer.…
Another metformin recall has been announced due to NDMA contamination.…
Plaintiffs are defending their right to file Zantac lawsuits in the face of an attempt by generic manufacturers and repackagers to have cases not involving actual claims of cancer dismissed.…
A year after the first warnings of Zantac NDMA contamination, the drug has been removed from store shelves, and cancer claims continue to be filed.…
Two lots of metformin extended release tablets from Nostrum Laboratories, Inc. have been recalled due to the presence of high levels of NDMA.…
A federal court is conducting an analysis of census data on Zantac lawsuits to get a better sense of common elements and claims in the cancer lawsuits.…
FDA inspectors say quality control issues at a RLC Labs facility led to the recall of 500 lots of thyroid medications last month.…
A Zantac lawsuit claims the recalled heartburn drug gave a man bladder cancer which required multiple surgeries and continuous medical monitoring.…
A Zantac lawsuit claims the recalled heartburn drug caused a man to develop tonsil cancer.…